Status:
COMPLETED
Short-term Clinical Follow-up of the Vascular Closure Device MANTATM in Minimally Invasive Cardiac Surgery
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Femoral Artery Injury
Aortic Valve Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
The percutaneous MANTA Vascular Closure Device is dedicated to the closure of large bore arteriotomies. It appears to be a safe and doable option for vascular access closure in patients undergoing tra...
Eligibility Criteria
Inclusion
- Subject voluntarily agreeing to participate in the study
- Subject \>= 18 years of age
- Patients operated between december 16, 2019 and june 30, 2021 from minimally invasive cardiac surgery with femoral cannulation for cardiopulmonary bypass in Dijon University Hospital
- Patients in whom the MANTA device has been used for femoral artery closure
Exclusion
- Not applicable
Key Trial Info
Start Date :
March 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT04802200
Start Date
March 17 2021
End Date
December 31 2021
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France